The KTC Solution

Today, there are two primary treatments for the disease — Dialysis or Kidney Transplant

0 k

Americans living with End–Stage Kidney Disease

Medicare Program; Alternative Payment Model Updates and the Increasing Organ Transplant Access (IOTA) Model, 89 Fed. Reg. 96280, 96294 (December 4, 2024).

0 k

Americans are on dialysis and 90,323 are on the kidney transplant waitlist

The Moran Company, The Living Organ Volunteer Engagement (LOVE) Act: Fiscal Implications (March 15, 2024), available from author.

> 0

Transplants were complete. The United States ranks 22nd in the world in transplants for people on dialysis and in 2024

The Moran Company, The Living Organ Volunteer Engagement (LOVE) Act: Fiscal Implications (March 15, 2024), available from author.

How can we support? Advocate and Educate.

Policy/Advocacy

Living Donor Rates Are Stagnant: There are two sources for kidney transplants: kidneys donated by deceased donors, and those donated by living donors.
Living donor organs are preferrable for two reasons:

There will never be sufficient deceased organs available to meet patient need

Matas AJ, Montgomery RA, Schold JD. The Organ Shortage Continues to Be a Crisis for Patients With End-stage Kidney Disease. JAMA Surg. 2023 Aug 1;158(8):787-788. doi: 10.1001/jamasurg.2023.0526. PMID: 37223921

Living donors last nearly twice as long as deceased donor kidneys, producing far better recipient health outcomes and avoiding individuals returning to the waitlist for a second transplant

“Given that only about 1% of deaths occur in a manner suitable for organ donation, there appears to be no possibility that any further increase in deceased donation will be sufficient to eliminate the shortage. Similarly, there is currently a considerable emphasis on minimizing the number of deceased donor kidneys recovered but not transplanted; however, at best, that alone might result in approximately 2000 more transplants per year, a mere dent in the problem

Matas AJ, Montgomery RA, Schold JD. The Organ Shortage Continues to Be a Crisis for Patients With End-stage Kidney Disease. JAMA Surg. 2023 Aug 1;158(8):787-788. doi: 10.1001/jamasurg.2023.0526. PMID: 37223921

Adding facilitators could radically change that figure, and drastically increase living donation, so that 49 of the 100 candidates actually complete the donation.

Elevating Patient Navigation for the Living Donor and Recipient

Clinical studies demonstrate how living donor transplantation can increase by providing a transplant facilitator to the potential recipient and the potential donor to support identifying qualified donors and supporting the complex pre–donation and donation process.

Assisting Potential Recipients in Identifying Donors

Expecting advanced CKD and ESKD patients to find living donors isn’t a stable solution. Studies have shown that dialysis patients working with a transplant facilitator to arm them with the language to ask, identify potential donors, and in some cases even initial the outreach for the potential recipient, significantly increase the likelihood that a living donor can be found. By implementing a transplant facilitator, The Johns Hopkins “Champions” program reported a massive increase in recipients identifying living donors following the assistance of a facilitator.

Assisting Potential Donors in Navigating the System

Providing individuals who volunteer to be considered for living donation a facilitator provides necessary support to understand the extensive medical testing and eventual surgery. This support has also shown an increase in prospects of living donation. Today only 7 candidates of every 100 potential living donors willing to be screened make it to donation.

Kidney Transplant Is the Optimal Treatment – Both from a Health and Fiscal Perspective: Kidney transplant is the “optimal treatment.”

The health benefits of transplants are enhanced by the cost savings. A private study, using Congressional Budget Office scoring conventions, estimated each kidney transplant saves the Medicare program $800,000 over ten years. Adding 6,000 new living donor transplants over the next decade would reduce Medicare spending by $6.6 billion.

The Moran Company, The Living Organ Volunteer Engagement (LOVE) Act: Fiscal Implications (March 15, 2024), available from author.

“Although not a cure for kidney disease, a transplant can help a person live longer and improve quality of life. On average, patients experience 14 to 16 years of function from a kidney from a living kidney donor, while few people survive more than a decade on dialysis.”

Medicare Program; Alternative Payment Model Updates and the Increasing Organ Transplant Access (IOTA) Model, 89 Fed. Reg. 96280, 96294 (December 4, 2024).

Advocating for enhanced cost reimbursement for living donors will support an increase in living donor transplants.

Kidney Transplant Collaborative (KTC) Praises Representatives DelBene, Bucshon, Schrier, and Miller for Advancing Legislation to Expand Access to Life-Saving Kidney Transplants
Read More
Kidney Transplant Collective, Bi-Partisan Coalition in Congress Calls on Biden Administration to Take Action
Read More
Kidney Transplant Collaborative Applauds Bipartisan Coalition Calling for Increased Transplant Access and Greater Support for Living Kidney Donors
Read More

Modify the 2024 physician fee schedule which created a direct payment program for “Principal Illness Facilitators,” principally in the oncology and respiratory arenas, through which physicians could be reimbursed for hiring facilitators to assist patients through treatment.

CMS could amplify the existing Principal Illness Navigator program and create a specialized Living Kidney Donor Transplant Facilitator program for ESKD and advanced CKD patients who are potential transplant recipients and for the prospective living donors who are prepared to help them. The regulation would need to only include four proposals:

Modification 1. Clearly include patient facilitation for recipients as viable reimbursable activity, removing any room for interpretation, to include assistance in finding a living donor.

Modification 2. Establish patient facilitation for living donors as viable reimbursable activity.

Modification 3. Increase the existing program’s payment rate so as to support the specialized services needed for living donation facilitation.

Modification 4. Clarify the 2024 statement that co-pays must be made and state that potential living donors are not responsible for copays.

Grants

It is essential that the kidney transplant community continue to aggressively explore innovative new kidney transplant methods, strategies and programs that can be implemented at the state, regional and federal level to significantly increase kidney donation and transplantation.

Pulsatile Perfusion of Kidneys from Procurement to Delivery at Accepting Centers

Using Machine Learning Predictions to Improve Utilization and Reduce Discards in Deceased Donor Organ Allocation

Kidney Transplant in Rapid Organ Recovery from Donation after Uncontrolled Circulatory Death Occurs

Using Shared Decision Making to Improve Kidney Transplant

Deceased Donor Kidney Chains

Private Sector

Innovative private sectors solutions to come in the kidney transplant space